Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function
Sign Up to like & getrecommendations! Published in 2017 at "Toxicology and Applied Pharmacology"
DOI: 10.1016/j.taap.2016.12.011
Abstract: Abstract Intravesical gemcitabine has recently been introduced for the treatment of superficial bladder cancer and has a favourable efficacy and toxicity profile in comparison to mitomycin c (MMC), the most commonly used chemotherapeutic agent. The… read more here.
Keywords: gemcitabine; cell lines; urothelial function; urothelial cells ... See more keywords